On Friday 31 October, eight European healthcare associations, including EFPIA, Medicines for Europe and AnimalhealthEurope, expressed their “serious concerns” at the lack of a specific assessment of the impact of ECHA’s proposed restriction on PFASs (per- and polyfluoroalkylated substances) for human and veterinary medicinal products.
These organisations are denouncing the European Chemicals Agency’s (ECHA) decision to exclude “other medical applications” - including...